John Zhang
6Patents
1h-index
11Co-inventors
40Inventor score
Filing activity: Feb 16, 2011 → Feb 23, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9132145B2 | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus | Human Necessities | 3 | Active |
| US8574635B2 | Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus | Human Necessities | 0 | Active |
| US11242398B2 | Anti-OX40 antibodies and methods of activating OX40 | Chemistry; Metallurgy | 0 | Active |
| US11248049B2 | Immunotherapy using antibodies that bind Programmed Death 1 (PD-1) | Chemistry; Metallurgy | 0 | Active |
| US11332531B2 | Immunotherapy using antibodies that bind programmed death ligand-1 (PD-L1) | Chemistry; Metallurgy | 0 | Active |
| US11629184B2 | Calcitonin gene-related peptide (CGRP) antagonist antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.